4//SEC Filing
SYNAGEVA BIOPHARMA CORP 4
Accession 0001246360-13-003268
CIK 0000911326operating
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 4:42 PM ET
Size
5.4 KB
Accession
0001246360-13-003268
Insider Transaction Report
Form 4
Glynn Michael
SVP Global Business Operations
Transactions
- Award
Stock Option (Right to Buy)
2013-06-06+40,000→ 40,000 totalExercise: $40.32Exp: 2023-06-06→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]25% of the total number of shares subject to the option vest and become exercisable on June 6, 2014 and 1/36 of the remainder of the shares subject to the option shall vest and become exercisable monthly thereafter.
Documents
Issuer
SYNAGEVA BIOPHARMA CORP
CIK 0000911326
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000911326
Filing Metadata
- Form type
- 4
- Filed
- Jun 9, 8:00 PM ET
- Accepted
- Jun 10, 4:42 PM ET
- Size
- 5.4 KB